Increased total and high density lipoprotein cholesterol with apoprotein changes resembling streptozotocin diabetes in tetrachlorodibenzodioxin (TCDD) treated rats.
Center E. Grossi Paoletti, Chemotherapy and Pharmawgnosy Chairs, University of Milano, 20129 Milano, Italy.
A
A
Poli
G
G
Franceschini
L
L
Puglisi
C R
CR
Sirtori
D000818:Animals; D001059:Apoproteins / Q000737:chemistry*; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood*; D003720:Densitometry; D003921:Diabetes Mellitus, Experimental / Q000097:blood*; D004305:Dose-Response Relationship, Drug; D005215:Fasting; D006863:Hydrogen-Ion Concentration; D007525:Isoelectric Focusing; D008074:Lipoproteins / Q000097:blood* / Q000648:ultrastructure; D008297:Male; D000072317:Polychlorinated Dibenzodioxins / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013311:Streptozocin / Q000633:toxicity; D013997:Time Factors; D014280:Triglycerides / Q000097:blood; D014461:Ultracentrifugation
D001059:Apoproteins; D008076:Cholesterol, HDL; D008074:Lipoproteins; D000072317:Polychlorinated Dibenzodioxins; D014280:Triglycerides; D013311:Streptozocin; D002784:Cholesterol